CompletedNCT02699190

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Studying Leukodystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Adeline Vanderver, MD
Children's Hospital of Philadelphia
Enrollment
236 enrolled
Eligibility
18 years · All sexes
Timeline
20172024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02699190 on ClinicalTrials.gov

Other trials for Leukodystrophy

Additional recruiting or active studies for the same condition.

See all trials for Leukodystrophy

← Back to all trials